IGFBP7 and gastric cancer: Extended to the present study, we acknowledged that IGFBP7 might also have early diagnostic value in gastric cancers with an AUC of 0.773 (95% CI [0.701–0.845]) in the training cohort and 0.778 (95% CI [0.673–0.882]) in the independent validation cohort.